4/A
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-020248
CBO & COO acquired 16,334 shares (option exercise)
From the SEC's structured data for this filing
CRISPR Therapeutics AG Filed Acc 0001209191-21-020248
CBO & COO acquired 16,334 shares (option exercise)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…